Evidence map›Paper›PMID 41611714›Full record

ArticleNature communications2026

Divergent photochemical ring-replacement of isoxazoles.

Yan Xu, Lorenzo Poletti, Enrique M Arpa, Baptiste Roure, Alessandro Ruffoni, Daniele Leonori

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yan XuInstitute of Organic Chemistry, RWTH Aachen University, Aachen, Germany.
Lorenzo PolettiInstitute of Organic Chemistry, RWTH Aachen University, Aachen, Germany.
Enrique M ArpaInstitute of Organic Chemistry, RWTH Aachen University, Aachen, Germany.ORCID http://orcid.org/0000-0003-1288-6059
Baptiste RoureSchool of Chemistry, University of Manchester, Manchester, UK. baptiste.roure@rwth-aachen.de.ORCID http://orcid.org/0000-0002-6459-8094
Alessandro RuffoniOtto Diels - Institute of Organic Chemistry, Christian Albrecht Universitat zu Kiel, Kiel, Germany. aruffoni@oc.uni-kiel.de.ORCID http://orcid.org/0000-0001-8617-2548
Daniele LeonoriInstitute of Organic Chemistry, RWTH Aachen University, Aachen, Germany. daniele.leonori@rwth-aachen.de.ORCID http://orcid.org/0000-0002-7692-4504

Funding

EC | EC Seventh Framework Programm | FP7 People: Marie-Curie Actions (FP7-PEOPLE - Specific Programme "People" Implementing the Seventh Framework Programme of the European Community for Research, Technological Development and Demonstration Activities (2007 to 2013)) 101150311EC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 European Research Council (H2020 Excellent Science - European Research Council) 101086901
6 · The paper itself

Abstract

Isoxazoles, oxazoles, and other five-membered heteroaromatics are prevalent motifs in core structure of pharmaceuticals and agrochemicals. In early-stage drug discovery, it is common practice to prepare libraries of analogues featuring different heterocyclic cores and this generally requires a de novo synthesis for each scaffold. A valuable but currently unavailable strategy would involve the possibility for direct heterocycle "ring-replacement". Here we report a photochemical platform for the selective conversion of isoxazoles into oxazoles, pyrazoles, pyrroles, and isothiazoles by exploiting excited-state reactivity. Starting from a successful isoxazole-to-oxazole transformation, we uncover position-sensitive reactivity that prompted computational investigation. These insights guide a systematic reactivity survey and reveal a solvent-controlled deconstruction-reconstruction pathway via α-ketonitrile intermediates. This approach enables scaffold diversification without de novo synthesis, affording access to five distinct azole classes under mild conditions. The method's selectivity, functional group tolerance, and late-stage applicability suggest broad utility in heterocyclic library design for pharmaceutical research.

Identifiers

PMID41611714
PMCPMC12957462

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.